Allogeneic hematopoietic stem cell transplantation is the treatment of choice for high-risk
hematological malignancies such as acute myeloid and lymphocytic leukemia …

Several clinical trials have compared the safety and efficacy of umbilical cord blood
transplantation (UCBT) with haploidentical transplantation (HIT) in patients with …

The donor selection algorithm for cord blood (CB) with regards to matched related and
unrelated donors has not been fully investigated. To assess the potential of CB …

2. Baron F, Ruggeri A, Beohou E, et al. RIC versus MAC UCBT in adults with AML: A report
from Eurocord, the ALWP and the CTIWP of the EBMT. Oncotarget. 2016; 7 (28): 43027 …

The utilization of cord blood as a source of stem cells for transplantation has decreased in
recent years. Although cord blood transplantation (CBT) is an established practice for the …

One of the truly revolutionary advances in hematopoietic cell transplantation (HCT) is the
increasingly successful use of alternative donors, thereby allowing the delivery of a …

Haploidentical hematopoietic stem cell transplantation (Haplo-SCT) and umbilical cord
blood transplantation (UCBT) are two important alternatives when a matched sibling donor …

Umbilical cord blood (UCB) and haploidentical donor stem cell sources represent common
alternative donor strategies used when a matched sibling donor (MRD) or matched …

Human umbilical cord blood (UCB) is a potential source of hematopoietic stem cells (HSCs)
capable of reconstituting hematopoiesis after myeloablative [1-4] or nonmyeloablative [5] …

For patients without a human leukocyte antigen (HLA)-matched sibling or unrelated donor,
options include transplantation from HLA-mismatched related donors, HLA-mismatched …